Summit Therapeutics Insider Boost: Anand Bhaskar Exercises 30,000-Share Option, Signaling Confidence
Summit Therapeutics insider activity: Chief Accounting Officer Anand Bhaskar’s 30k‑share option grant signals confidence and long‑term commitment, boosting investor optimism amid growing buzz and pipeline milestones.
4 minutes to read